Please enable Javascript
Alan Skarbnik, MD
Articles by Alan Skarbnik, MD
'The HemOnc Pulse' Live Part Two: The Question of MRD in CLL Therapy
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse Live
|
August 22, 2024
Mazyar Shadman, MD; Meghan Thompson, MD; Alan Skarbnik, MD continue their discussion on MRD in CLL during HOP Live 2024.
Listen Now
'The HemOnc Pulse' Live Part One: The Question of MRD in CLL Therapy
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse Live
|
September 3, 2024
This episode explores questions in CLL with Mazyar Shadman, MD; Meghan Thompson, MD; Alan Skarbnik, MD during HOP Live 2024.
Listen Now
'The HemOnc Pulse' Live: Unanswered Questions in Aggressive Non-Hodgkin Lymphoma
Greg Nowakowski, MD
The HemOnc Pulse Live
|
May 28, 2024
An expert panel convened at the "HemOnc Pulse" Live meeting in Chicago explores unanswered questions in DLBCL management.
Listen Now
'The HemOnc Pulse' Live 2024 in Chicago: CAR-T Unanswered Questions
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse Live
|
July 26, 2024
Live from Chicago, the panel discussed unanswered questions in CAR-T.
Listen Now
What are the Controversies Surrounding MRD in Blood Cancers?
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse: MRD
|
September 12, 2024
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
Listen Now
ASH 2023: What Is the Latest ‘Practice-Changing’ Research in DLBCL?
Chadi Nabhan, MD, MBA, FACP
Aggressive B-Cell Lymphoma
|
December 14, 2023
In this episode of The HemOnc Pulse, Alan Skarbnik, MD, of Novant Health, discusses practice-changing research in DLBCL.
Listen Now